Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice by unknown
Regulation  by Interferon c~ of Immunoglobulin 
Isotype  Selection  and Lymphokine  Production 
in Mice 
By Fred D. Finkelman,* Antonela Svetic,~; Ion Gresser,￿82 
Clifford Snapper,$ Joanne Holmes,* Paul P. Trotta,** 
Ildy M. Katona,*  II and William C. Gause~ 
From the Departments of *Medicine, ~Microhiology, SPathology, and IIPediatrics  of the 
Uniformed Servkes University of the Health Sciences, Bethesda, Maryland 20814; the 
￿82  of Viral Ontology, UTR 274 CNRS, Groupe de Lat~ I.R.S.C.-BP8, 94801 
Villejuif Cedex, France; and the **Department of Biotechnology-Biochemistry,  Schering-Plough 
Research, Bloomfield, New Jersey 07003 
Summary 
Antigens and infectious agents that stimulate  interferon ot(IFN-t~) production in mice induce 
antibody responses that are predominantly of the immunoglobulin (Ig)G2a isotype and contain 
little or no IgE. This suggested  the possibility  that IFN-ot might have a role in directing Ig 
isotype selection. Consistent with this possibility, we have found that injection of mice with 
recombinant mouse IFN-ol suppresses IgE secretion,  enhances  IgG2a secretion,  and has no 
independent effect on IgG1 secretion in mice stimulated with a foreign anti-IgD antibody. Injection 
of mice with polyinosinic acid.polycytidylic acid (poly I.C), an inducer of macrophage IFN-ol 
production, also suppresses the anti-IgD antibody-induced IgE response and stimulates the IgG2a 
response; these effects are blocked by a sheep antibody that neutralizes mouse IFN-oL//~ Both 
recombinant IFN-c~ and poly I-C have maximum IgE suppressive and IgG2a stimulatory effects 
when injected early in the anti-IgD antibody-induced immune response. Addition of IFN-ot to 
mouse B cells cultured with lipopolysaccharide (LPS) + interleukin 4(I1,4) suppresses both IgG1 
and IgE production, but much less potently than IFN-% IFN-c~ suppresses anti-IgD antibody- 
induced increases in the level of splenic I1,4 mRNA, but enhances the anti-IgD antibody-induced 
increase in the splenic level of IFN-3' mRNA. These results are consistent  with the effect of 
IFN-o~ on Ig isotype expression in mice, as I1,4 stimulates IgE and suppresses IgG2a secretion 
while IFN-3" exerts opposite  effects. These observations  suggest  that antigen presenting cells, 
by secreting IFN-oe early in the course of an immune response, can influence the nature of that 
response both through direct effects on B cells and by influencing the differentiation  of T cells. 
D 
ifferential production of cytokines during an immune 
response has important regulatory effects on the na- 
ture of that response. Responses in mice that are character- 
ized by substantial II.-4 but little IFN-3' production generate 
IgG1- and IgE-secreting cells, with little IgG2a (1, 2). Re- 
sponses in which the production of IFN-~' predominates are 
characterized by IgG2a production, activation of macrophages 
to kill intracellular  parasites, delayed type hypersensitivity, 
and little or no IgE production (2-7). 
The correlations between cytokine production and selec- 
tion of Ig isotypes in large part reflect direct effects of I1,4 
and IFN-3, on B lymphocytes.  In the presence of bacterial 
LPS, IL-4 stimulates purified B cells to secrete IgG1 and IgE, 
and suppresses IgG2a production, while IFN-3~ has the op- 
posite effect (8-11). Furthermore, anti-I1,4 antibody blocks 
IgE responses and can enhance IgG2a responses in vivo (12, 
13). IFN-3' has the same effects and also inhibits production 
in vivo of IgG1, and anti-IFN-3, antibody can enhance produc- 
tion in vivo of IgG1 and IgE and inhibit the production of 
IgG2a (7). 
Cytokines, however, may also have indirect effects on Ig 
isotype selection. Mouse CD4 § T cell clones prepared after 
longterm immune stimulation tend to produce exclusively 
either of two sets of cytokines. Thl cells secrete I1,2, IFN-3', 
and lymphotoxin, but not Ib4, Ib5, I1,6,  or II,10, while 
Th2 cells have the opposite cytokine secretory profile (3, 4, 
14). IFN-3~ inhibits the proliferation  of Th2, but not Thl 
cells (15), while I1,10 inhibits cytokine secretion by Thl, but 
not Th2 cells (16). Thus, once one CD4 + T cell subset be- 
comes dominant during an immune response, a mechanism 
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resting  CD4 +  T  cells  are  induced  during  activation  to 
differentiate into cells that secrete predominantly Thl or Th2 
cytokines are less clear. One possibility is that non-T cells 
might be stimulated early in an immune response to produce 
factors  that can influence T  cell differentiation. 
IFN-c~ is an attractive candidate for a cytokine that might 
influence the characteristics  of an immune response  both 
through direct actions on effector cells and through the regu- 
lation of T cell differentiation. Large quantities of IFN-ol are 
produced early in some immune responses by macrophages 
(17). Thus, macrophages might simultaneously present an- 
tigen to T cells, activating them, and influence their pathway 
of differentiation by secreting IFN-ot. Second,  IFN-ol, like 
IFN-% inhibits IgE production by human PBCs that are cul- 
tured with IL-4 (18). Third, the injection of mice with killed, 
fixed,  Brucella  abortus  (BA), ~ an agent known to stimulate 
the production of  both IFN-y and IFN-ot (7, 19, 20), blocks 
the generation of both IgG1 and IgE responses in vivo (7). 
Administration of anti-IFN-y antibody to these mice blocks 
the inhibitory effect of BA on IgG1 production, but fails to 
block its inhibitory effect on IgE production (7). We hypothe- 
sized that the production of IFN-o~ in response to BA might 
be responsible  for this IFN-3,-independent effect. 
To investigate the possible role of IFN-c~ in the regulation 
of Ig isotype secretion we have studied the effects of recom- 
binant IFN-ot, agents that induce endogenous IFN-cr produc- 
tion, and a polyclonal anti-IFN-od/~ antibody on the Ig iso- 
types secreted in mice that have been stimulated to make a 
large polyclonal Ig response by the injection of anti-IgD an- 
tibodies. These studies provide evidence that IFN-o~ produced 
early in the course of an immune response inhibits IgE produc- 
tion and stimulates IgG2a production, and that these effects 
may result from a decrease in T cell IL-4 gene expression  as 
well as from a direct effect on the B cell. 
Materials and Methods 
Animals.  BALB/c  female  mice were purchased from the Small 
Animals Division of the National Cancer Institute, NIH, and were 
used at 8 to 12 wk-of-age. The experiments herein were conducted 
according to the principles set forth in the Guide for the Care and 
Use of Laboratory Animals, Institute of Animal Resources, Na- 
tional Research Council, Department of Health, Education and 
Welfare Publication (National Institutes of Health) 78-23. 
Antibodies.  The following  antibodies  were prepared as described: 
affinity purified goat anti-mouse IgD (GaMe5) (21); FF1-4D5 (a 
mouse IgG2a mAb of the b allotype specific  for IgD of the a allo- 
type) (22); H/~  ~ 1 (a mouse IgG2b mAb of the b allotype specific 
for IgD of the a allotype) (23); XMG-6 (a rat IgG1 that neutralizes 
mouse IFN-3') (24); J4-1 (a rat IgG1 anti-NP mAb, used as a con- 
trol) (23); 24G2 (a rat IgG2b antibody  specific  for the mouse  Fc3,1LII  ) 
(25); a polyclonal sheep antibody that neutralizes mouse IFN-c~ 
and IFN-/~ (SalFN-od/3) (26); and normal sheep serum. 
t Abbreviations used this paper: BA, Brucella abortus; GaMS, affinity-purified 
goat antibody  specific  for IgD; HPRT, hypoxanthine-guanine  phosphor- 
ibosyl  transferase;  MaMa,  a combination  of  two mouse  aUoantibodies  specific 
for mouse IgD; poly I.C, polyinosinic  acid.polycytidylic  acid. 
Immune Reagents.  Recombinant murine IFN-ot, generously 
provided by Schering-Plough  Research (Bloomfield,  NJ), was diluted 
in 0.5 M NaC1/0.02 M Tris, pH 7.4, and kept frozen at  -70~ 
until used. Different lots had 0.85-1.7  x  107 IU/mg of antiviral 
activity. All lots were free of detectable LPS by the limulus assay. 
Recombinant mouse IL-4 (a gift of Dr. William E. Paul, Bethesda, 
MD) was produced in the baculovirus system and purified by pas- 
sage over an anti-IL-4 (11Bll) (27) affinity column, followed by 
further purification by HPLC. Ib4 was quantitated with a CT.4S 
proliferation assay (28). Polyinosinic acid-polycytidylic  acid (poly 
I.C) was purchased from Boehringer Mannheim Biochemicals  (In- 
dianapolis, IN). Lipopolysaccharide  (LPS W, extracted from Esche- 
richia coli 0111:B4) was purchased from Difco Laboratories, Inc. 
(Detroit,  MI). 
Cell Cultures.  Enriched  populations of B cells were obtained 
from BALB/c  spleens  by treatment with anti-Thy 1 (mAb 30H12) 
(29) plus complement. Small dense B cells were obtained by dis- 
continuous Percoll gradient centrifugation.  Cells that formed a band 
between 60% and 70% Percoll and had a density of 1.081-1.086 
g/ml were considered to be resting B cells. Cells were cultured 
for 6 d at 1.25 x  105 cells/ml in 6-well flat-bottom Costar plates 
(Costar, Cambridge, MA) in medium RPMI 1640 (Biofluids,  Rock- 
ville, MD) supplemented with 10% fetal bovine serum, 2 mM 
t-glutamine, 0.05 mM 2-ME, 50 /~g/ml penicillin, and 50/~g/ml 
streptomycin. LPS was added to some cultures at 20 Izg/ml, IL-4 
was added to some cultures at 10,000 U/ml, and anti-IFN-3' mAb 
(XMG-6) was added to some cultures at 5 #g/ml. 
Quantitation oflg Isotypes.  Serum  IgG1 and IgG2a were quan- 
titated by radial immunodiffusion, using rabbit anti-mouse IgG1 
antiserum (30) and a sheep anti-mouse IgG2a antiserum purchased 
from The Binding Site, Ltd. (Birmingham, UK). IgG1 and IgG2a 
in culture supernatants, and IgE in serum and in culture superna- 
rants, were quantitated by ELISA (31). 
Quantitation of Cytokine mRNA.  A reverse transcriptase-PCR 
approach (32) was used to determine relative quantities of mRNA 
for Ib4 and IFN-3' (details below). This approach has been shown 
to reproducibly detect less than  1.3-fold differences in mRNA 
content. 
Isolation and Purification of RNA.  ILNase-free  plastic and water 
were used throughout the assay. Tissues were homogenized in 
RNAzol (Cinna/Biotecx, Friendswood, TX) at 50 mg of spleen 
per ml. 0.2 ml of chloroform was added per 2 ml of homogenate, 
the samples were tightly covered, shaken vigorously for 15 s, and 
then incubated on ice for 15 min. The suspension was centrifuged 
at 12,000 g (4~  for 15 min. The aqueous phase was transferred 
to a fresh tube, to which an equal volume of isopropanol was added. 
After mixing, the samples were incubated for 45 min at  -200C. 
Samples were centrifuged for 15 min at 12,000 g (4~  The resul- 
tant tLNA precipitate was transferred to a 1,2 ml centrifuge tube 
and washed twice with 75% ethanol. The final preparation was 
suspended in water and quantitated spectrophotometrically. 
To ascertain  whether the RNA was intact and whether the con- 
centration had been determined correctly, the purified RNA (10 
#g) was electrophoresed on a 2%  formaldehyde gel containing 
ethidium bromide (33). The gel was photographed and individual 
lanes were examined  for the presence of the 18S and 28S ribosomal 
bands, the absence of RNA degradation, and whether equal loading 
of RNA on each lane had occurred. 
Reverse Transc@tase Reaction.  The coupled reverse transcrip- 
tion/polymerase chain reaction used here was a modification  of that 
described by Diamond et al. (34). Reverse transcription of RNA 
was performed in a 25/xl final volume containing: (a) 2.5/xl of 
a 10 mM mix of all four deoxynucleotide triphosphates (dNTP); 
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8.3, 375 mM KC1, 15 mM MgC12; (c) 2 #1 0.1 M DT'I~ (d) 2 #1 
random hexamers (0.5 U/25 #I); (e) 3 #1 total RNA (1 #g/#l); 
(f) 8.7 #1 double distilled H20. This was mixed, heated to 70~ 
for 5 min to denature the RNA, cooled on ice and 1.2 #1 of reverse 
transcriptase (RT) (200 U/ml) was added. This was again mixed, 
centrifuged  to pellet any precipitate, and incubated at 37~  for 
60 rain.  The reaction was next heated at 90~  for 5 min,  then 
quickly cooled on ice. 
Polyraerase  Chain Reaction.  The primers for amplification  during 
the PCR have been described (32). Product amplified from cDNA 
could be distinguished from any amplified from genomic DNA, 
because the primers amplified genomic DNA introns  as well as 
exons. To the 12 #1 of KT mix the following components were 
added: (a) 4 #1 dNTP mix (10 mM);  (b) 5 #1 10x  PCR buffer 
(500 mM  KCI,  100 mM Tris-HC1, 15  mM  MgC12,  1 mg/ml 
BSA); (c) 5 #1 sense primer (0.2 #g/#l); (d) 2 #1 anti-sense primer 
(0.2 #g/ml); (e) 24 #1 double distilled H20; (f) 0.5 #1 Taq poly- 
merase (5 U/ml). After an initial incubation at 95~  for 5 rain, 
temperature cycling was initiated with each cycle as follows: (a) 
95~  for 1 min (denaturation);  (b) 53-55~  (depending on the 
cytokine to be amplified)  for 1 min (annealing of  primers); (c) 72~ 
for 3 min (primer extension). For each gene product, the optimum 
number of cycles was determined experimentally, and was defined 
as that number of  cycles that would achieve  a detectable concentra- 
tion which was well below saturating  conditions. 
To verify that equal amounts of RNA were added in each PCR 
reaction within an experiment and to verify a uniform amplification 
process, hypoxanthine-guanine phosphoribosyl transferase  (HPRT) 
mRNA was also reverse  transcribed  and amplified  for each assay  (32). 
Detection of the Amplified Product by Southern Blot Analysis.  10 
#1 of the final reaction mix was run on a 1% agarose gel at 120 
volts for 3 h. The gel was then denatured by soaking for 45 rain 
in several volumes of 1.5 M NaC1, 0.5 N NaOH with constant, 
gentle agitation. The gel was then rinsed briefly in deionized water, 
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Figure 1.  Effect  of IFN-c~ on the increases in spleen weight and serum 
Ig levels in GaMfi-injected  mice. BALB/c mice (5/group) were injected 
i.v. with GaM8 (800 #g) or with GaM8 plus anti-IFN-3"  mAb (1 mg). 
Mice were injected i.p. with saline or the doses of recombinant mouse 
IFN-ot shown twice daily 2, 3, and 4 d after GaMeS injection. Mice were 
bled and sacrificed  8 d after  GaM~ injection. Spleens  were  weighed, serum 
IgG1 and IgG2a levels  were determined  by radial immunodiffusion, and 
serum IgE levels  were  determined  by ELISA.  Data are shown as geometric 
means and standard errors. Crosshatched  circles show values observed  in 
untreated mice. 
and neutralized by soaking for 45 rain in several volumes of I M 
Tris (pH 7.4),  1.5 M NaCI at room temperature  with constant 
agitation. 
The DNA was then transferred to a nylon membrane by stan- 
dard blotting procedures (35). The membrane was UV crosslinked 
using the UV Stratalinker 1800 (Stratagene, La Jolla, CA). Blots 
were prehybridized at 42~  for 6 h in a solution containing 6x 
SSPE and 1% SDS. The probes were specifically selected to hy- 
bridize to a portion of the amplified segment between the nucleo- 
tide sequences complementary to the primers. This ensured the 
identity of the segment amplified. After hybridization, blots were 
washed for 15 rain in 6x  SSPE, 0.1% SDS and then 3-4 rain in 
2 x or lx SSPE  at 49~  Autoradiographs were exposed at - 70~ 
using Kodak XAR-2 film. 
Video Densitometry.  Following autoradiography, the resultant 
bands on the XAR-2 film represent areas of specific  probe hybrid- 
ization.  The band intensity  was quantitated  using  one of two 
methods:  (a) With the JAVA video densitometry  system (Jandel 
Scientific, Corte Madera, CA), several  autoradiographic exposures 
were taken of each blot to ensure that the signal from each band 
was in the linear range of the film response. (b) Blots were exposed 
to a phosphor screen that was then read directly with a 400 series 
phosphoimager (Molecular Dynamics, Sunnyvale, CA). The high 
sensitivity and broad dynamic range of the phosphoimager facili- 
tated quantitation. 
Results 
Effect of lFN-ol on Increases in Serum Immunoglobulin (Ig) 
Levels and Spleen Weight in CaM&injected Mice.  To determine 
the effect of recombinant mouse IFN-o~ on the humoral im- 
mune response to GaMe, mice were injected i.v. with 800 #g 
of GaM~ and 2, 3, and 4 d later were injected twice daily 
i.p. with 0.2 ml of 0.5 M  NaC1/0.02 M  Tris,  pH 7.4, or 
with the same buffer containing 1, 5, or 25 #g of rlFN-c~. 
Analysis of sera obtained 8 d after GaM~ injection indicated 
that GaM~ stimulated an approximately 15-fold increase in 
serum IgG2a and a greater than 100-fold increases in serum 
IgG1 and IgE levels (Fig. 1). In addition, an approximately 
five-fold increase in spleen weight was observed in GaM6- 
injected mice. IFN-oc at the highest dose tested, suppressed 
serum IgE levels by greater than 90% and IgG1 levels by ap- 
proximately 60%, while enhancing serum IgG2a levels two- 
three-fold, but had no effect on spleen weight. To determine 
if any of these effects were dependent upon the presence of 
IFN-%  additional groups of mice that were injected with 
both GaM~ and  1 rag of anti-IFN-3, mAb were similarly 
treated with buffer or IFN-c~.  In  the  absence of IFN-oe, 
anti-IFN-3, enhanced the GaM#-induced IgG1 and IgE re- 
sponses  and suppressed the GaM/~-induced  IgG2a response. 
IFN-c~ strongly suppressed the IgE response and stimulated 
the IgG2a response in these mice, but had no effect on the 
IgG1 response. Thus, IFN-o~, independently of IFN-T, can 
inhibit IgE production and enhance IgG2a production, but 
has no independent effect on the IgG1 response. The effects 
of IFN-ol on Ig isotype secretion were not simply the result 
of altered kinetics of Ig secretion. When administered on days 
two through four after GaM~ injection, IFN-c~  enhanced 
serum IgG2a levels and inhibited serum IgE levels both 8 
and 10 d after GaM/~ treatment (Fig.  2).  However, a large 
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Figure 2.  Effect  of IFN-cr on serum Ig levels in GaMe-injected mice, 
BALB/c mice were treated with GaMe5 _+  anti-lFN-3" _+  IFN-ot as in 
the legend to Fig. 1. and were bled 8 and 10 d after GaM5 injection. Geo- 
metric means and standard errors of serum Ig levels are shown. 
day 8 to day 10 decrease  in serum IgE levels was seen in GaM/~- 
treated mice, while IgE levels remained at a low, but stable 
level in mice that also received IFN-ot. 
IFN-cr Has an Early Suppressive Effect on the Generation of 
an IgE Response in GaM&injected Mice.  Previous studies have 
demonstrated that a 3-d course of IFN-3, has its greatest sup- 
pressive effect on IgE secretion by GaM/~-injected  mice if ad- 
ministered 2 through 4 d after GaM/~ injection (7). To deter- 
mine if IFN-c~ suppression of the IgE response followed the 
same kinetic pattern, GaM/t-treated mice were injected twice 
daily with IFN-ot on the day of and on the 2 d following 
GaM/~ injection, or on days 2 through 4 after GaM/k In this 
experiment, a suboptimal  dose of IFN-ot was used (10/zg 
twice a d), so that minor time-related differences in IFN-ot 
suppression of IgE production could be optimally detected, 
and all mice were treated with anti-IFN-3, mAb, to elimi- 
nate any effects of this cytokine on the IgE response. Sera 
were obtained 8 d after GaMe5 injection and serum Ig levels 
were measured. Treatment with IFN-a, on the day of and 
on the 2 d following GaM8 injection, or on days 2 through 
4 after GaMe5, decreased serum IgE levels by a factor of ap- 
proximately three, and had no significant effect on IgG1 levels 
(data not shown). 
Endogenous IFN~/~ Production Suppresses IgE Secretion.  To 
investigate the possibility that endogenously produced IFN-o~ 
or IFN-3 could effect Ig isotype selection in the same way 
as injected recombinant IFN-o~, we studied the effects of in- 
jecting poly I.C, a potent inducer of endogenous IFN-od~ 
production (36-38), on the immune responses induced by 
GaM/L Mice in this experiment also received  anti-IFN-3, mAb, 
because we have found that poly I.C can induce the produc- 
tion of IFN-y as well as IFN-ot/3 (Snapper, C.M., H. Yama- 
guchi, J.F. Urban, Jr., and F.D. Finkelman, manuscript sub- 
mitted for publication).  Injection of a single dose of poly 
I.C (100/~g i.p.) on the day of or 1 or 2 d after GaM/~ sup- 
pressed the GaMe-induced IgE response by approximately 
90%, but had no suppressive  effect on serum IgG1 levels (data 
not shown). 
Since poly I.C has important biological effects in addition 
to the induction of IFN production, it was possible that the 
effects of poly I-C on Ig isotype regulation were unrelated 
to its stimulation of an IFN-ol response. To determine the 
relationship  between the poly I.C  effects and IFN-a  (or 
IFN-B) production, we studied the ability of a sheep anti-IFN- 
c~/fl antiserum to block the effects of poly I.C on Ig isotype 
selection in anti-IgD antibody-treated mice. In these experi- 
ments, a pair of mouse IgG2 antibodies of the b allotype that 
are specific for IgD of the a allotype (H#'/1 and FF1-4D5, 
abbreviated as MaM6) were used instead of GaMe. Because 
poly I.C rapidly stimulates macrophage production of IFN-oe, 
mice were injected with anti-IFN-ot//5 antiserum and anti- 
IFN-3, mAb 1 d before their injection with the anti-/~ mAbs 
and poly I.C. In mice pre-treated with anti-IFN-3, mAb plus 
a control sheep serum, a 200/zg dose of poly I-C inhibited 
the IgE response induced by MaM~ by greater than 90% (Fig. 
3). No inhibition of the IgE response by poly I.C was ob- 
served, however,  when mice were pretreated  with  sheep 
anti-IFN-c~/3 rather than with the control sheep serum. In 
contrast, serum IgG2a levels were approximately twice as high 
in mice treated with MaMa, poly I.C, and anti-IFN-qr mAb 
in the presence of control sheep serum as in mice injected 
with the same agents in the presence of sheep anti-IFN-cff3 
antiserum (Fig. 3). As expected, neither poly I-C nor anti- 
IFN-oE/~ antiserum had a significant effect on the IgG1 re- 
sponse induced by MaM/~ in the presence of anti-IFN-3' mAb. 
These observations demonstrate that the effects of poly I.C 
on Ig isotype selection in anti-/~ plus anti-IFN-3, antibody 
treated mice, which closely resemble the effects of recom- 
binant IFN-ol,  result from the stimulation of endogenous 
IFN-oe and/or IFN-B  production. 
IFN-cr/~ Has a Relatively Modest Effect on lmmunoglobulin 
(Ig) Isotype Secretion in Vitro by Lipopolysaccharide (LPS)-activated 
Splenic B Cells.  To determine if IFN-a (or IFN-fi, which 
binds to the same receptor) had any ability to influence Ig 
isotype selection in vitro in the absence of T lymphocytes, 
T cell-depleted spleen cells were cultured in vitro with LPS 
in the presence or absence of 104 U of recombinant mouse 
IL-4,  +_  10 units of recombinant mouse IFN-3~ or 1-10,000 
U of recombinant mouse IFN-cg. IgG1, IgG2a, and IgE levels 
in culture supernatants 6 d after the initiation of culture were 
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Figure 3.  The inhibitory  effect  ofpoly I-C on the IgE response  to MaM/t 
plus anti-IFN-"/mAb  is blocked  by anti-IFN-odB  antibody.  BALB/c  mice 
(5/group) were injected i.v. with 100 #g of each of two MaM~ mAbs 
(H~/1 and FF1-4D5) + anti-IFN-'y  mAb, and were injected  at the same 
time with 200/~g of poly I-C. Some  groups of mice were injected i.v. 
1 d before  MaM~ injection  with 0.1 ml of either normal sheep serum or 
sheep anti-mouse IFN-oe/fl  antiserum. Additional groups of mice were 
left untreated  or were  injected  with poly  I.C in the absence  of  other treat- 
meat. Mice were bled 8 d after injection  with MaM/f and/or poly I.C. 
Geometric means and standard errors of serum [g levels are shown. 
determined by ELISA (Fig. 4). At a concentration of 10 U/ml, 
IFN-ot had no effect on the LPS-induced IgG2a response or 
the LPS  +  IL-4-induced IgG1 response, and inhibited the 
LPS  +  IL-4-induced IgE response by a factor of 2 (Fig. 4, 
upper panel). Increasing the concentration of IFN-ot to 1,000 
U/ml increased inhibition of the LPS +  IL-4-induced IgG1 
and lgE responses to factors of 3 and 4, respectively, but still 
had no significant effect on the LPS-induced IgG2a response. 
In contrast, IFN-3' at a concentration of 10 U/ml inhibited 
the LPS  +  Ib4-induced IgG1 and IgE responses by factors 
of 70 and 12,  respectively, and enhanced the LPS-induced 
IgG2a response by a factor of 8 (Fig.  4, lower panel). Addi- 
tion of anti-IFN-y mAb to cultures inhibited the effects of 
IFN-% but not those of IFN-ot (data not shown). Similar 
observations were made in additional in vitro experiments. 
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Figure 4.  Effects  of IFN-o~ and IFN-3" on Ig secretions by mouse B 
calls cultured with LPS _+ IL-4. Small, T call-depleted  spleen cells were 
cultured with 20/zg/ml of LPS +- 104 U/rot of recombinam mouse I1,4 
_+ 10 U/ml of recombinant mouse IFN-~/(lower  panel) or with the con- 
centrations of recombinant mouse IFN-a shown (upper panel). After 6 
d of culture superuatants were analyzed  by ELISA for IgG1, IgG2a, and 
IgE content. IFN-cr and IFN-"/inhibited IgG1 production  by cells cul- 
tured with LPS in the absence  of 1I,-4 to a similar extent  as they inhibited 
IgG1 production  by cells cultured with LPS + IL-4, although the addi- 
tion of Ib4 increased  IgG1 production  over  50-fold. The addition of Ib4 
to cell cultures reduced  IgG2a production  to barely detectable  levels. No 
detectable  lgE was produced  in the absence  of IF4. Increasing  the IFN-c~ 
concentration in cultures to 104 U/ml was highly toxic to calls, and sup- 
pressed all Ig production. 
Enhances  IFN-'y  mRNA  Levels in  Anti-c5 Antibodytreated 
Mice.  The weak and similar inhibitory effects of IFN-c~ on 
IgG1 and IgE responses in an in vitro system, and the lack 
of a stimulatory effect of IFN-c~ on IgG2a production in this 
system, as compared to IFN-oe's strong in vivo inhibition 
of IgE, but not IgG1 production, and stimulation of IgG2a 
production, suggested that IFN-oe might indirectly inhibit 
in vivo IgE secretion by inhibiting the production of IL-4. 
This would be consistent with the observation that although 
II.-4 costimulates both IgG1 and IgE production and inhibits 
IgG2a  production in vitro  (8-11),  anti-Ib4  and  anti-IL-4 
receptor mAbs completely block IgE production and enhance 
IgG2a production, but have little effect on IgG1 production 
in GaMes-injected mice (12, 13). To investigate whether IFN-ot 
might selectively modulate the production of IL-4 in vitro, 
1183  Finkdman  et al. Figure 5.  IFN-c~ inhibits the GaMe-induced increase in splenic IL-4 mRNA levels and enhances the increase in splenic IFN-3, mRNA levels. BALB/c 
mice (5/group) were left untreated or were injected i.v. with 100/zg each of two anti-5 mAbs (HSa/1  and FF1-4D5), and 1 mg each of anti-Fcq,  RII 
mAb (24G2)  and anti-IFN-3, mAb (XMG-6). Some mice also were injected i.p. with 25,000  U  of recombinant mouse IFN-o~, twice daily, on the 
day of and 1 and 2 d after antibody administration. Two additional groups of mice that received the mAb cocktail were injected at the same time 
i.p. with 200/~g of poly I.C; one group was pretreated 1 d earlier with 0.2 ml of sheep anti-mouse IFN-a/B antiserum, the other group with a 
control sheep serum, mRNA was prepared from spleens 4 d after mAb injection, cDNA was prepared from mRNA and amplified with primers specific 
for Ib4 or IFN-~/DNA, as described in Materials and Methods, subjected  to electrophoresis,  and hybridized with specific probes by the Southern 
blot technique.  The blots were exposed to phosphor screens and the resulting images were analyzed with a Molecular Dynamics phosphoimager. 
we used a reverse transcriptase-PCR technique (32) to quan- 
titate splenic II-4 and IFN-y mRNA levels in mice injected 
with MaM6 antibody plus anti-IFN-~/mAb in the presence 
or absence of recombinant mouse IFN-ct. Levels were deter- 
mined 4 d after anti-IgD antibody injection, because previous 
studies have shown that both cytokine genes are expressed 
at this time (32) and that both II-4 and IFN-'y have an im- 
portant effect at this time on Ig isotype selection (7,  39). 
Injection of mice with a combination of MaMa, anti-FcTRII 
mAb, and anti-IFN-3, mAb induced 34- and 4-fold increases 
in the expression of splenic I1-4 and IFN-3r mKNA, respec- 
tively (Fig.  5), but had no effect on HPKT mRNA levels 
(data not shown). Injection of mice with 25,000 U of IFN- 
oL twice daily on the day of and the 2 d after MaM/~ injection 
decreased the level of splenic I1-4 mKNA by a factor of 4 
and increased the splenic level of IFN-y mKNA by a factor 
of approximately 3 (rig.  s).  Poly I.c, injected as a single 
200/zg dose on the day of MaM~ injection also inhibited 
Ib4 gene expression;  this effect was largely blocked if mice 
were pretreated with sheep anti-IFN-cdB antiserum rather 
than normal sheep IgG (Fig. 5). Poly I.C stimulated an ap- 
proximately nine-fold increase  in IFN-~  gene expression, 
regardless  of whether  mice  were  pretreated  with  anti- 
IFN-ol/3 or control antiserum. This is consistent with our 
previous observation that poly I.C directly stimulates IFN-3,, 
as well as IFN-oz secretion (Snapper, C.M., H. Yamaguchi, 
J.F. Urban, Jr., and F.D. Finkdman, manuscript submitted 
for publication). 
Discussion 
The discoveries that two cytokines, IL-4 and IFN-% can 
have striking, and usually opposite effects on Ig isotype se- 
lection (1, 2, 11), and that normal CD4 + T cells and T  cell 
clones can differ markedly in their relative secretion of these 
two cytokines (3), raised two additional questions: (a) Are 
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and (b) What regulates the differentiation of virgin, resting 
CD4 + T  cells into effector  calls that secrete high or low 
ratios of Ib4/IFN-7. The data presented in this paper make 
it likely that IFN-a (and presumably, IFN-3), is in the group 
of cytokines that regulates Ig isotype selection indirectly by 
decreasing the ratio of IL-4/IFN-',/that is secreted by T cells 
as well as through a direct effect on B cells. This interpreta- 
tion is supported by observations that: (a) recombinant IFN-ce 
inhibits IgE secretion and enhances IgG2a secretion when 
injected into anti-IgD antibody-injected mice; (b) these effects 
are not IFN-'y dependent, since they are observed in mice 
injected with an anti-IFN-3, mAb; (c) the effect of IFN-c~ 
is mimicked  by poly I.C, which stimulates endogenous IFN-c~ 
secretion;  (d) a sheep antiserum, that neutralizes  IFN-cz and 
IFN-3, blocks the Ig isotype modifying effects of poly I.C 
in  mice stimulated with  a  combination of anti-IgD  and 
anti-IFN-3/mAbs; (e) IFN-c~ is considerably less potent than 
IFN-3/in its inhibition of IgG1 and IgE production by LPS 
+  IL-4-stimulated B ceUs in vitro, and, unlike IFN-% has 
no ability to enhance IgG2a production by LPS-activated B 
ceils; and (f) IFN-a treatment of anti-IgD antibody-treated 
mice decreases the splenic level of IL-4 mRNA but increases 
the level of splenic  IFN-3/mRNA.  The observation that 
IFN-ot inhibits in vivo IgG1 production in the absence of 
anti-IFN-7 mAb, but has no effect on IgG1 production in 
the presence of anti-IFN-7 mAb, suggests that the in vivo 
effect of IFN-cz on this isotype is entirely due to the stimula- 
tion of increased  IFN-3' production. 
Our overaU interpretation must be made, however, with 
some caveats: (a) Anti-IgD antibody is an atypical immunogen. 
It binds to, and is processed and presented to T cells by, the 
majority of B ceils, with the result that T cell activation and 
cytokine secretion are greatly enhanced as compared to the 
levels that are usually observed during a response to a con- 
ventional T cell-dependent antigen. This large degree of T 
cell activation contributes to the generation of an enormous 
Ig response in anti-IgD antibody-treated mice 0 0' 31). While 
these peculiarities  of the anti-IgD antibody system make it 
ideal for the detection of cytokine effects on Ig isotype and 
cytokine gene expression,  there is no assurance that IFN-cz 
will have the same effects in responses to conventional an- 
tigens that it has in anti-IgD antibody-injected mice. It is 
reassuring,  however,  that the effects of IFN-7 and Ib4 on 
Ig isotype selection  that were initially observed in GaM/~ 
antibody-injected mice have since been confirmed in other 
systems (2). (b) Since no mAbs that potently neutralize both 
IFN-a and IFN-fl are available, it was necessary to use a poly- 
clonal sheep anti-IFN-a/fi antibody in studies performed 
to demonstrate that the effect of poly I.C on Ig isotype selec- 
tion resulted from IFN-ot/fl production. Since this sheep an- 
tibody was prepared against purified natural mouse IFN-ol 
and IFN-fl, it is impossible to be completely certain that it 
does not have some ability to neutralize cytokines in addi- 
tion to IFN-ot/3. Tests have demonstrated, however that it 
lacks anti-II.-2, IFN-% or TNF antibody activity.  (c) Our 
observation that IFN-oe treatment inhibits splenic IL-4 mRNA 
levels, and enhances IFN-3, mRNA levels, demonstrates that 
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IFN-ot differentially  regulates cytokine gene expression.  It 
does not, however, prove that IPN-cz modifies the secretion 
of these cytokines to the same extent, since protein synthesis 
and secretion may be at least partially controlled at transla- 
tional or posttranslational levels. (d) In as much as we havre 
quantitated mRNA levels in unfractionated spleen cells, we 
cannot identify with certainty the call population or popula- 
tions in which IFN-a affected IL-4 and IFN-3, gene expres- 
sion. It seems likely, however, that the effects observed were 
predominantly in CD4 + T  ceUs, since T  cells are the only 
cells in GaM/~-treated mice that secrete detectable Ib4 (40) 
and since CD4 + spleen cells from these mice contain greater 
than 100-fold more IL-4 encoding mRNA than do CD4- 
spleen cells (32). 
Our interpretation draws support from the observation that 
most viruses, which induce the production of large quanti- 
ties of IFN-cc/fl as well as IFN-%  induce the production 
of IgG2a as their predominant Ig isotype (41). Studies are 
currently being performed to determine the relative contri- 
butions of IFN-odfl and IFN-7 to IgG2a predominance in 
these mice. A role for IFN-a/3 in the determination of T 
cell differentiative  pathways  is also compatible with results 
of investigations of mice infected with the protozoan para- 
site Leishmania major. T ceUs of BALB/c mice infected with 
this parasite secrete a high ratio of IL-4/IFN-% while T cells 
of Leishmania-infected C57BL/6 mice secrete a high ratio of 
Ib4/IFN-~ ratio (6). This difference in cytokine secretion 
is at least partially responsible for the progressive disease ob- 
served in BALB/c mice, as opposed to the limited disease seen 
in C57BL/6 mice, as well as for the expected differences in 
the Ig isotypes secreted by these different mouse strains (5, 
6). Interestingly, macrophages from BALB/c mice produce 
much less IFN-ee  than do C57BL/6  macrophages, when 
stimulated with agents such as poly I.C (42). Experiments 
are being performed to determine whether this correlation 
is fortuitous or reflective of an importarlt control mechanism 
in the establishment of different T  cell cytokine secretory 
patterns. 
IFN-ot is not the only factor that can influence the ratio 
of ID4/IFN-3~  secretion by T lymphocytes. IFN-7 inhibits 
the proliferation of T cell clones that secrete II~4, IL-5, and 
IL-10 (Th2 cells) but not the proliferation of T  cell clones 
that secrete Ib2 and IFN-3' (Thl ceils) (15). Ibl0 inhibits 
cytokine production by Thl, but not by Th2 cells (16). Nei- 
ther IFN-3' nor ILl0, however, has yet been shown to influence 
the differentiation of uncommitted, resting T cells in vitro 
or to influence T  cell cytokine production in vivo. In con- 
trast, while IL-4 has not been shown to affect cytokine secre- 
tion by established Thl or Th2 cells, it promotes the differen- 
tiation of T  cells into Ib4-secreting cells in some in vitro 
systems, and appears to directly or indirectly promote IL4 
secretion and inhibit IFN-~ secretion in some in vitro and 
in vivo systems (43-46). 
IFN-oe differs from Ib4, IL-10, and IFN-3' in that it is pro- 
duced predominantly by non-T cells, and especially by a cell 
type, the macrophage (37, 38),  that has an important role 
in the presentation of antigen to T cells. Thus, the capacity 
of an antigen to stimulate macrophage production of IFN-ce, which can occur soon after macrophage and antigen first come 
into contact, may allow virgin T cells to simultaneously be 
presented with processed antigen, that leads to their activa- 
tion, plus a cytokine that induces them to differentiate in 
a Thl direction. However, while II.-4, II:10, and IFN-y ap- 
pear to be produced predominantly by T cells, their produc- 
tion by other cell types has also been described.  We would 
propose that B cell production of I1:10 (47), NK cell produc- 
tion of IFN-3, (48), mast cell or basophil production of I1:4 
(49-51),  and the presumed production of other cytokines by 
non-T cells early in the course of an immune response  may, 
like macrophage production of IFN-o~, act to influence the 
direction of T cell differentiation. This hypothesis would sug- 
gest that auxiliary properties of antigens, that lead to their 
stimulation of specific cytokines by non-T cells, rather than 
the expression  of specific T  cell epitopes,  regulates differen- 
tial T  cell cytokine production. 
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